• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织形态计量学测量并不能预测结直肠癌手术后的生存情况。

Tissue morphometric measurements do not predict survival following colorectal cancer surgery.

机构信息

Colorectal Surgery Unit, Concord Hospital, Concord, NSW, 2139, Australia.

Concord Institute of Academic Surgery, Concord Hospital, Building 20, Level 1, Hospital Road, Concord, NSW, 2139, Australia.

出版信息

World J Surg Oncol. 2024 Aug 22;22(1):216. doi: 10.1186/s12957-024-03496-1.

DOI:10.1186/s12957-024-03496-1
PMID:39174976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11340191/
Abstract

BACKGROUND

Ex vivo tissue morphometric (TM) measurements have been proposed as a quality marker for colorectal cancer (CRC) surgery. However, their survival associations require clarification. This study aimed to evaluate the feasibility of capturing TM measurements based on ex vivo fresh specimen images and explore the association between these TM measurements and survival outcomes.

METHODS

A prospective cohort study at Concord Hospital, Sydney was conducted with Stage I to III CRC patients (2009-2019) who underwent an anterior resection (AR) or right hemicolectomy (RH). Using high-resolution digital photographs of fresh CRC specimens, ex vivo tissue morphometric (TM) measurements-resected mesentery area (TM A), distances from high vascular tie to tumour (TM B) and bowel wall (TM C), and bowel length (TM D)-were recorded using Image J. Overall survival (OS) and disease-free survival (DFS) estimates and their associations to clinicopathological variables were investigated with Kaplan-Meier and Cox regression analyses. Linear regression models tested association between TM measurements and lymph node (LN) yield.

RESULTS

Of the 1,425 patients who underwent CRC surgery, TM measurements were performed on 312 patients, with an average age of 69.4 years (SD 12.3), of whom 52.9% were male. The majority had an AR (57.8%). Among AR patients, a 5-year OS rate of 77.4% and a DFS rate of 70.1% were observed, with TM measurements bearing no relationship to survival outcomes. Similarly, RH patients exhibited a 5-year OS rate of 67.2% and a DFS rate of 63.1%, with TM measurements again showing no association with survival. Only TM D (P = 0.02) measurements were associated with the number of LNs examined.

CONCLUSION

This study successfully demonstrates the feasibility of measuring TM measurements on photographs of ex vivo fresh specimens following CRC surgery. The lack of association with survival outcomes questions the utility of TM measurements as a quality metric of CRC surgery.

摘要

背景

离体组织形态计量学(TM)测量已被提议作为结直肠癌(CRC)手术的质量标志物。然而,它们的生存关联仍需要阐明。本研究旨在评估基于离体新鲜标本图像获取 TM 测量的可行性,并探讨这些 TM 测量与生存结果之间的关联。

方法

这是在悉尼康科德医院进行的一项前瞻性队列研究,纳入了 2009 年至 2019 年间接受前切除术(AR)或右半结肠切除术(RH)的 I 期至 III 期 CRC 患者。使用新鲜 CRC 标本的高分辨率数字照片,使用 Image J 记录离体组织形态计量(TM)测量值 - 切除肠系膜面积(TM A)、高血管结扎到肿瘤的距离(TM B)和肠壁(TM C)以及肠长度(TM D)。使用 Kaplan-Meier 和 Cox 回归分析评估总生存(OS)和无病生存(DFS)估计值及其与临床病理变量的关联。线性回归模型测试了 TM 测量值与淋巴结(LN)产量之间的关联。

结果

在接受 CRC 手术的 1425 名患者中,对 312 名患者进行了 TM 测量,平均年龄为 69.4 岁(SD 12.3),其中 52.9%为男性。大多数患者接受了 AR(57.8%)。在 AR 患者中,观察到 5 年 OS 率为 77.4%,DFS 率为 70.1%,TM 测量值与生存结果无关。同样,RH 患者的 5 年 OS 率为 67.2%,DFS 率为 63.1%,TM 测量值与生存也无关联。只有 TM D(P=0.02)测量值与检查的淋巴结数量相关。

结论

本研究成功证明了在 CRC 手术后对离体新鲜标本的照片进行 TM 测量的可行性。与生存结果无关,质疑 TM 测量值作为 CRC 手术质量指标的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d5/11340191/10b928be9fb8/12957_2024_3496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d5/11340191/d1f29ad6b6cf/12957_2024_3496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d5/11340191/10b928be9fb8/12957_2024_3496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d5/11340191/d1f29ad6b6cf/12957_2024_3496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d5/11340191/10b928be9fb8/12957_2024_3496_Fig2_HTML.jpg

相似文献

1
Tissue morphometric measurements do not predict survival following colorectal cancer surgery.组织形态计量学测量并不能预测结直肠癌手术后的生存情况。
World J Surg Oncol. 2024 Aug 22;22(1):216. doi: 10.1186/s12957-024-03496-1.
2
Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.淋巴结比率作为Ⅲ期结直肠癌的独立预后指标:尤其适用于检查的淋巴结少于12个的情况。
Tumour Biol. 2014 Nov;35(11):11685-90. doi: 10.1007/s13277-014-2484-x. Epub 2014 Aug 21.
3
Prognostic value and characteristics of N1c colorectal cancer.N1c 期结直肠癌的预后价值和特征。
Colorectal Dis. 2018 Sep;20(9):O248-O255. doi: 10.1111/codi.14289. Epub 2018 Jun 30.
4
The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer.淋巴结比率对结直肠癌患者手术结局的影响。
Sci Rep. 2024 Jul 31;14(1):17689. doi: 10.1038/s41598-024-68576-4.
5
Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.精氨酸酶-1 的过表达是结直肠癌患者预后不良的指标。
Pathol Res Pract. 2019 Jun;215(6):152383. doi: 10.1016/j.prp.2019.03.012. Epub 2019 Mar 5.
6
A novel hand-assisted laparoscopic versus conventional laparoscopic right hemicolectomy for right colon cancer: study protocol for a randomized controlled trial.一项针对右半结肠癌的新型手辅助腹腔镜与传统腹腔镜右半结肠切除术的比较:一项随机对照试验的研究方案。
Trials. 2017 Jul 26;18(1):355. doi: 10.1186/s13063-017-2084-3.
7
Splenic flexure cancer survival: a 25-year experience and implications for complete mesocolic excision (CME) and central vascular ligation (CVL).脾曲癌的生存率:25年的经验及对完整结肠系膜切除术(CME)和中央血管结扎术(CVL)的启示
ANZ J Surg. 2023 Jul-Aug;93(7-8):1861-1869. doi: 10.1111/ans.18434. Epub 2023 Mar 28.
8
Novel lymph node ratio predicts prognosis of colorectal cancer patients after radical surgery when tumor deposits are counted as positive lymph nodes: a retrospective multicenter study.当将肿瘤结节计为阳性淋巴结时,新型淋巴结比率可预测结直肠癌患者根治性手术后的预后:一项回顾性多中心研究。
Oncotarget. 2016 Nov 8;7(45):73865-73875. doi: 10.18632/oncotarget.12076.
9
Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.线粒体DNA拷贝数作为指导错配修复缺陷的II期和III期结直肠癌患者辅助化疗的生物标志物:寻求益处与避免危害
Ann Surg Oncol. 2024 Sep;31(9):6320-6330. doi: 10.1245/s10434-024-15759-y. Epub 2024 Jul 10.
10
Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancer.微卫星不稳定高结直肠癌中阴性淋巴结计数的预后意义。
World J Surg Oncol. 2024 Jul 19;22(1):186. doi: 10.1186/s12957-024-03469-4.

本文引用的文献

1
Complete mesocolic excision for colon cancer: current status and controversies.完整结肠系膜切除术治疗结肠癌:现状与争议。
ANZ J Surg. 2024 Mar;94(3):309-319. doi: 10.1111/ans.18741. Epub 2023 Oct 18.
2
Splenic flexure cancer survival: a 25-year experience and implications for complete mesocolic excision (CME) and central vascular ligation (CVL).脾曲癌的生存率:25年的经验及对完整结肠系膜切除术(CME)和中央血管结扎术(CVL)的启示
ANZ J Surg. 2023 Jul-Aug;93(7-8):1861-1869. doi: 10.1111/ans.18434. Epub 2023 Mar 28.
3
Recurrence and colon cancer-specific death in patients with large bowel obstruction requiring urgent operation: a competing risks analysis.
需要紧急手术的大肠梗阻患者的复发和结肠癌特异性死亡:竞争风险分析。
Colorectal Dis. 2021 Oct;23(10):2604-2618. doi: 10.1111/codi.15807. Epub 2021 Jul 23.
4
Routine CT evaluation of central vascular ligation in patients undergoing complete mesocolic excision for sigmoid colon cancer.常规 CT 评估在接受完整结肠系膜切除术治疗乙状结肠癌患者中的中央血管结扎术。
Colorectal Dis. 2021 Aug;23(8):2030-2040. doi: 10.1111/codi.15723. Epub 2021 Jun 10.
5
CME versus D3 Dissection for Colon Cancer.结肠癌的CME与D3淋巴结清扫术对比
Clin Colon Rectal Surg. 2020 Nov;33(6):344-348. doi: 10.1055/s-0040-1714237. Epub 2020 Nov 2.
6
What factors determine specimen quality in colon cancer surgery? A cohort study.哪些因素决定了结直肠癌手术标本质量?一项队列研究。
Int J Colorectal Dis. 2020 May;35(5):869-880. doi: 10.1007/s00384-020-03541-x. Epub 2020 Feb 28.
7
Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis.接受新辅助放疗的直肠癌患者直肠切除术后的淋巴结获取情况:一项系统评价和荟萃分析。
Eur J Cancer. 2017 Feb;72:84-94. doi: 10.1016/j.ejca.2016.10.031. Epub 2016 Dec 24.
8
Trends in pathology and long-term outcomes after resection of colorectal cancer: 1971-2013.1971 - 2013年结直肠癌切除术后的病理学趋势及长期预后
ANZ J Surg. 2017 Jan;87(1-2):34-38. doi: 10.1111/ans.13758. Epub 2016 Sep 20.
9
Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision.沿胚胎学平面进行的结肠癌手术:完整结肠系膜切除术的系统评价
Int J Colorectal Dis. 2016 Sep;31(9):1577-94. doi: 10.1007/s00384-016-2626-2. Epub 2016 Jul 28.
10
Long-term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision.基于解剖学的结肠癌切除手术技术的长期结果:与完整结肠系膜切除术的结果比较。
Colorectal Dis. 2016 Jul;18(7):676-83. doi: 10.1111/codi.13159.